• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    55.07 Down 0.75(1.34%) Feb 27, 4:00PM EST
    |After Hours : 55.06 Down 0.01 (0.01%) Feb 27, 4:36PM EST
    Add to Portfolio
    Prev Close:55.82
    Open:55.76
    Bid:N/A
    Ask:55.25 x 200
    1y Target Est:78.67
    Beta:1.74
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:54.92 - 55.80
    52wk Range:41.99 - 80.21
    Volume:225,132
    Avg Vol (3m):261,960
    Market Cap:1.08B
    P/E (ttm):98.34
    EPS (ttm):0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 1.34%1.08B
    LLYUp 0.20%74.42B
    MRKDown 0.71%166.89B
    RHHBYUp 0.80%191.83B

    Key Statistics

    Forward P/E (1 yr):17.16
    P/S (ttm):16.93
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.15
    Quarterly EPS Est (Mar-15) :0.27
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):0.56

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback